Journal Articles
2019

SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to
promote atherosclerosis
L. Huang
K. L. Chambliss
X. Gao
I. S. Yuhanna
E. Behling-Kelly

See next page for additional authors

Follow this and additional works at: https://academicworks.medicine.hofstra.edu/articles
Part of the Pediatrics Commons

Recommended Citation
Huang L, Chambliss KL, Gao X, Yuhanna IS, Behling-Kelly E, Bergaya S, Ahmed M, Michaely P, Luby-Phelps
K, Shaul PW, . SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis. .
2019 Jan 01; 569(7757):Article 5693 [ p.]. Available from: https://academicworks.medicine.hofstra.edu/
articles/5693. Free full text article.

This Article is brought to you for free and open access by Donald and Barbara Zucker School of Medicine Academic
Works. It has been accepted for inclusion in Journal Articles by an authorized administrator of Donald and Barbara
Zucker School of Medicine Academic Works. For more information, please contact academicworks@hofstra.edu.

Authors
L. Huang, K. L. Chambliss, X. Gao, I. S. Yuhanna, E. Behling-Kelly, S. Bergaya, M. Ahmed, P. Michaely, K.
Luby-Phelps, P. W. Shaul, and +5 additional authors

This article is available at Donald and Barbara Zucker School of Medicine Academic Works:
https://academicworks.medicine.hofstra.edu/articles/5693

HHS Public Access
Author manuscript
Author Manuscript

Nature. Author manuscript; available in PMC 2019 October 24.
Published in final edited form as:
Nature. 2019 May ; 569(7757): 565–569. doi:10.1038/s41586-019-1140-4.

SR-B1 Drives Endothelial Cell LDL Transcytosis via DOCK4 to
Promote Atherosclerosis
Linzhang Huang1, Ken L. Chambliss1, Xiaofei Gao2,3, Ivan S. Yuhanna1, Erica BehlingKelly1,†, Sonia Bergaya4, Mohamed Ahmed1, Peter Michaely5, Kate Luby-Phelps5, Anza
Darehshouri5, Lin Xu6, Edward A. Fisher4, Woo-Ping Ge2,3, Chieko Mineo1,5, and Philip W.
Shaul1,*

Author Manuscript

1Center

for Pulmonary and Vascular Biology, Department of Pediatrics, University of Texas
Southwestern Medical Center,Dallas, TX 75390, USA

2Children’s

Research Institute and Department of Pediatrics, University of Texas Southwestern
Medical Center,Dallas, TX 75390, USA

3Departments

of Neuroscience, and Neurology and Neurotherapeutics, University of Texas
Southwestern Medical Center,Dallas, TX 75390, USA

4Department

of Medicine, Leon H. Charney Division of Cardiology, and the Marc and Ruti Bell
Program in Vascular Biology, New York University School of Medicine, New York, NY 10016, USA
5Department

of Cell Biology, University of Texas Southwestern Medical Center,Dallas, TX 75390,

USA

Author Manuscript

6Quantitative

Biomedical Research Center, Department of Clinical Sciences, and Department of
Pediatrics University of Texas Southwestern Medical Center,Dallas, TX 75390, USA

SUMMARY
Atherosclerosis, which underlies life-threatening cardiovascular disorders including myocardial
infarction and stroke1, is initiated by low density lipoprotein cholesterol (LDL) passage into the
artery wall and engulfment by macrophages, leading to foam cell formation and lesion
development2, 2, 3, 3. How circulating LDL enters the artery wall to instigate atherosclerosis is
unknown. Here we show in mice that scavenger receptor, class B type 1 (SR-B1) in endothelial
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cells mediates LDL delivery into arteries and its accumulation by artery wall macrophages,
thereby promoting atherosclerosis. LDL particles are colocalized with SR-B1 in endothelial cell
intracellular vesicles in vivo, and LDL transcytosis across endothelial monolayers requires its
direct binding to SR-B1 and an 8 amino acid cytoplasmic domain of the receptor that recruits the
guanine nucleotide exchange factor dedicator of cytokinesis 4 (DOCK4)4. DOCK4 promotes SRB1 internalization and LDL transport by coupling LDL binding to SR-B1 with Rac1 activation.
SR-B1 and DOCK4 expression are increased in atherosclerosis-prone regions of the mouse aorta
prior to lesion formation, and in human atherosclerotic versus normal arteries. These findings
challenge the long-held concept that atherogenesis involves passive LDL movement across a
compromised endothelial barrier. Interventions inhibiting endothelial delivery of LDL into the
artery wall may represent a new therapeutic category in the battle against cardiovascular disease.
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In atherosclerosis, the balance of actions of lipoprotein particles governs the severity of the
disorder and the likelihood that clinical cardiovascular events will occur. Whereas LDL that
enters the artery wall is the critical driver of atherogenesis, via binding to SR-B1 in
hepatocytes, high density lipoprotein particles (HDL) mediate reverse cholesterol transport
(RCT) to the liver for biliary disposal and are thereby antiatherogenic5. In addition, in
endothelial cells via SR-B1 and its adaptor PDZK1, HDL stimulates endothelial NO
synthase (eNOS)6, endothelial repair and anti-inflammatory processes which may also be
atheroprotective7. To determine how SR-B1 in endothelium impacts atherosclerosis, mice
lacking the receptor selectively in endothelium were generated (SR-B1ΔEC, Extended Data
Fig. 1a–i) and placed on apolipoprotein E null (apoE−/−) background. To our initial surprise,
compared with SR-B1 floxed (SR-B1fl/fl) controls, SR-B1ΔEC had markedly less
atherosclerosis. This was evident in both males and females, and in mice on mixed or
C57BL/6 background (Fig. 1a–e, Extended Data Fig. 2a–e,h–l), and it was phenocopied in
mice with genetically-induced or PCSK9-induced LDL receptor (LDLR) deficiency
(Extended Data Fig. 3a–e, 4a–e), underscoring the robustness of the phenotype. In stark
contrast, with selective silencing of SR-B1 in hepatocytes, atherosclerosis was more severe
and early deaths occurred related to coronary artery occlusions and fibrotic myocardial
lesions (Extended Data Fig. 4m–q), as observed in SR-B1−/−;apoE−/− mice8. In all models
tested the endothelial deletion of SR-B1 which yielded atheroprotection did not alter
circulating total cholesterol, triglyceride or HDL levels, or lipoprotein profile (Fig. 1f–i,
Extended Data Figs. 2f–g,m–n, 3f–i, and 4f–i). Endothelial SR-B1 also did not impact
inflammation-related gene expression in the aorta, or leukocyte-endothelial cell adhesion
under basal or TNFα-induced proinflammatory conditions (Extended Data Fig. 5a–k).
Importantly, endothelial loss of the SR-B1 adaptor protein PDZK1 (PDZK1ΔEC, Extended
Data Fig. 1j–o) had no effect on lesion severity (Extended Data Fig. 2o–s). Thus, in marked
contrast to its role in hepatocytes, in the absence of impact on circulating lipids or vascular
inflammation and independent of processes governed by PDZK1, SR-B1 in endothelium
promotes atherosclerosis.
Since SR-B1 is a receptor for both HDL and LDL9, and in cultured endothelial cells SR-B1
promotes LDL transcytosis10, the hypothesis was then tested that endothelial SR-B1
influences atherosclerosis by regulating LDL-related processes in the artery wall. DiIlabeled human native LDL (nLDL) transfer into the aorta was visualized in vivo by confocal
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fluorescence microscopy. Following IV injection, far less DiI-nLDL entered the aorta of SRB1ΔEC mice compared to SR-B1fl/fl controls (Fig. 1j–l). Since circulating oxidized LDL
(oxLDL) may also contribute to atherogenesis11, 12, DiI-labeled human oxLDL transfer was
also visualized, and it was similarly diminished in SR-B1ΔEC (Extended Data Fig. 6a–c,
Videos S1 and S2). Decreased human LDL transfer into the aorta in SR-B1ΔEC was
confirmed by quantification in aorta homogenates (Extended Data Fig. 3j–k, 4j–k, 6d–e,j–k),
and mouse LDL and IDL/VLDL uptake was also decreased (Extended Data Fig. 3l–m). As
such, the prior finding of less LDL accumulation in ex vivo perfused arteries from global
SR-B1−/− mice10 was likely related to loss of the receptor in endothelium. In SR-B1ΔEC
mice, Evans blue dye uptake in aorta was unaltered (Fig. 1m), and in mice with intact
endothelial SR-B1, anti-SR-B1 blocking antibody treatment lowered aorta LDL
incorporation (Extended Data Fig. 6f–g,l–m) and LDL and SR-B1 were colocalized in
endothelial cell intracellular vesicles (Fig. 1n, Extended Data Fig. 7). Moreover, whereas
FACS studies of CD45+, F4/80+ macrophages indicated no change in their number in the
artery wall in SR-B1ΔEC, fewer macrophages contained administered LDL (Fig. 1o–p,
Extended Data Fig. 5l, 6h–i). These collective observations indicate that endothelial SR-B1
mediates the transcellular transport of LDL from the circulation into the artery wall and the
formation of foam cells, thereby promoting atherosclerosis.
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The relative importance and mechanistic basis for SR-BI trafficking of LDL was then
explored in human aortic endothelial cells (HAEC). Regarding the initial step in LDL
transport, whereas SR-B1 knockdown decreased Di-I LDL uptake, PDZK1 ablation had no
effect (Extended Data Fig. 8a), as previously observed with HDL13. SR-B1 blocking
antibody and the chemical SR-B1 inhibitor BLT-1 also attenuated LDL uptake, and either
treatment or SR-B1 knockdown blunted LDL transcytosis across endothelial cell monolayers
(Extended Data Fig. 8b–d). Whether the loss of SR-B1 impairs the function of endothelial
cell caveolae, which mediate LDL transport14, 15, was assessed in studies of ligand-induced
eNOS activation. Whereas SR-B1 silencing predictably negated HDL activation of eNOS6,
stimulation by the eNOS agonist VEGF was unaffected (Extended Data Fig. 8e), paralleling
complete loss versus no change in vasodilation with HDL versus acetylcholine in aortic
rings from SR-B1−/− mice6. In contrast, cyclodextrin disruption of caveolae structure
blunted eNOS activation by both VEGF and HDL (Extended Data Fig. 8f). Thus, the
attenuation of LDL transport observed with the loss of SR-B1 from endothelial cells is not
related to an alteration of the caveolae microenvironment.

Author Manuscript

The capacity of other endothelial receptors for LDL to mediate transport of the lipoprotein
was also determined16–18. Whereas LOX-1 knockdown did not alter nLDL or oxLDL uptake
by HAEC (data not shown), RNAi silencing of the LDL receptor (LDLR) or CD36
attenuated uptake, and blocking antibodies had similar effect; however, neither LDLR nor
CD36 antibody blockade impacted nLDL or oxLDL transcytosis (Extended Data Fig. 8g–
m). Thus, amongst classical lipoprotein receptors, whereas LDLR, CD36 and SR-B1 all
promote LDL uptake by human endothelial cells, SR-B1 drives LDL transcytosis.
We next compared the capacity for endothelial LDL transcytosis by SR-B1 and activing
receptor-like kinase 1 (ALK1), to which LDL binding and transport has been previously
ascribed19. LDL transcytosis was decreased to a similar degree by the selective loss of SR-
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B1 or ALK1, and there was a further decline with their concurrent knockdown (Extended
Data Fig. 9a–f). Thus, both SR-B1 and ALK1 mediate LDL transcytosis in endothelial cells,
and they likely do so by different mechanisms. Importantly, endothelial ALK1 expression
was normal in SR-B1ΔEC mice (Extended Data Fig. 1f), such that the in vivo findings for
endothelial SR-B1 and artery LDL delivery, macrophage LDL uptake and atherosclerosis
can be attributed specifically to SR-B1.

Author Manuscript

We then determined if LDL binding to SR-B1 is required for LDL trafficking across
endothelium. Endogenous SR-B1 was silenced in HAEC, and expression was reconstituted
with wild-type SR-BI or 5 point mutant forms previously (M159E and T165E)20 or newly
identified (F171A, T175A, and E178A) to have attenuated LDL binding (Fig. 2a, Extended
Data Fig. 10a–c). Another point mutant, Q445A, with normal LDL binding (Extended Data
Fig. 10c) but disrupted SR-B1 interaction with plasma membrane cholesterol21 was also
tested. Whereas reintroduction of wild-type SR-B1 yielded nLDL and oxLDL uptake
comparable to that for endogenous SR-B1, cells expressing SR-B1 with decreased LDL
binding had markedly diminished LDL uptake; in contrast, cells harboring the Q445A
mutant displayed normal LDL uptake (Fig. 2b). The vast majority of LDL transcytosis by
SR-B1 was also attenuated if LDL binding was diminished (Fig. 2c). Thus, direct
association is essential to LDL trafficking by SR-B1 in endothelial cells.
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Since SR-B1 lacks the internalization sequence Tyr-X-X-θ (X is any amino acid and θ is a
bulky hydrophobic amino acid) characteristic of other LDL receptors22, we raised the
hypothesis that SR-B1 has an associated partner protein(s) required for its internalization
and endothelial LDL transcytosis. As a first test, we generated deletion mutants lacking the
C-terminal 15, 23 or 30 residues of SR-B1, designated ΔC15 (Δ495–509), ΔC23 (Δ487–509)
and ΔC30 (Δ480–509) (Fig. 2a, Extended Data Fig. 10d–f). Whereas cells expressing ΔC15
had LDL uptake and transcytosis comparable to cells expressing full-length wild-type SRB1, both processes were attenuated in cells harboring ΔC23 or ΔC30 (Fig. 2d,e). These
findings suggested that residues 487–494 (IQAYSESL; Fig. 2a), which are highly conserved
in SR-B1 and unique to SR-B1 versus CD36 (Extended Data Fig. 10g), are required. To test
this possibility, alanines were substituted for the first four (IQAY) or last four (SESL)
residues, or single alanine substitutions were generated (Fig. 2a, Extended Data Fig. 10h–j).
Cells expressing the IQAY or SESL mutant or Y490A or S491A displayed dramatically
reduced nLDL and oxLDL uptake and transcytosis (Fig. 2f,g); Q488A had attenuated nLDL
uptake and transcytosis. Testing various receptor mutants, the findings for binding, uptake
and transcytosis were confirmed at nLDL concentrations that saturate LDLR binding
(100ug/ml), and endogenous CD36 and LDLR abundance was shown to be unaltered
(Extended Data Fig. 10k–n). As such, amino acids 487 to 494 in the C-terminal cytoplasmic
tail of SR-B1, IQAYSESL, are critical for LDL uptake and transcytosis by endothelial cells.
Next we tested the hypothesis that residues 487 to 494 of SR-B1 are required for receptor
interaction with a cytoplasmic protein(s) necessary for LDL transport. The interactomes of
N-terminally-HIS-tagged SR-B1 or SR-B1-ΔC23 in HAEC were evaluated by liquid
chromatography/tandem mass spectrometry. One of the 33 proteins demonstrating greater
interaction with HIS-SR-B1 versus HIS-SR-B1-ΔC23 was dedicator of cytokinesis 4
(DOCK4), which is a membrane-associated cytoplasmic protein that functions as a guanine
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nucleotide exchange factor (GEF) and a participant in actin cytoskeleton regulation4, 23, 24.
Coimmunoprecipitation experiments in HAEC confirmed DOCK4 interaction with amino
acids 487 to 494 of SR-B1 (Fig. 3a–b), and nLDL and oxLDL caused similar 72 to 94%
increases in SR-B1-DOCK4 coupling (Fig. 3c). In vivo coexpression of SR-B1 and DOCK4
was demonstrated in aortic endothelium (Fig. 3d), and compared to the atherosclerosisresistant greater curvature of the aortic arch, both SR-B1 and DOCK4 mRNA levels were
increased in the atherosclerosis-prone lesser curvature prior to lesion formation (Fig. 3e–f).
Furthermore, in three independent, publicly-available patient cohorts (Fig. 3g–l) both SR-B1
and DOCK4 expression was greater in atherosclerotic arteries versus normal arteries (Fig.
3g–l).
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Since DOCK4 mediates PDGF receptor internalization in fibroblasts24, whether SR-B1 is
internalized in endothelial cells, and if so, whether DOCK4 is required was then interrogated
in HAEC. Upon the resumption of endocytosis with warming from 4°C to 37°C in the
presence of nLDL or oxLDL, the internalization of cell surface biotin-labeled SR-B1 was
demonstrable in cells expressing DOCK4, and DOCK4 knockdown attenuated the
internalization (Fig. 4a,b). In contrast, transferrin receptor internalization was not affected
by DOCK4 deletion, revealing that DOCK4 does not influence endothelial cell SR-B1
endocytosis nonspecifically. It was further found that DOCK4 impacts the degree of LDL
binding to SR-B1 but not to LDLR or CD36 (Fig. 4c,d). Importantly, silencing of DOCK4
suppressed SR-B1-dependent LDL uptake and transcytosis assessed using either DiI-labeled
or 125I-labeled LDL (Fig. 4e,f, Extended Data Fig. 9g–j), and requirements for both SR-B1
and DOCK4 in LDL transcytosis were confirmed using total internal reflection fluorescence
(TIRF) microscopy (Extended Data Fig. 9k–l). In contrast, whereas HDL transcytosis was
decreased by SR-B1 silencing as previously shown13, DOCK4 knockdown had no effect
(Fig. 4g), indicating cargo-specific participation of DOCK4 in SR-B1 transport of
lipoproteins in endothelial cells. Since DOCK4 is a GEF for Rac14, Rac1 participation in
LDL trafficking was evaluated. Treatment with LDL caused Rac1 activation, the activation
was prevented by silencing either SR-B1 or DOCK4 (Fig. 4h,i), and attenuation of the
activation (FExtended Data Fig. 9m) blunted LDL uptake by SR-B1 (Figure 4j). Thus,
through a dynamic partnership with DOCK4 serving as a GEF for Rac1, SR-B1 mediates
endothelial cell LDL transcytosis to deliver circulating LDL into the subendothelial space to
be engulfed by macrophages that become foam cells and promote atherosclerotic lesion
formation (Fig. 4k).
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It has long been believed that the delivery of circulating LDL into the artery wall that
instigates atherosclerosis entails its passive movement through a compromised endothelial
barrier at lesion-prone sites, which display higher rates of endothelial senescence and
apoptosis, and reduced proliferative reserve and repair capacity25–27. We now reveal that
active transcellular LDL transport by SR-B1 in the endothelium drives atherogenesis. With
mechanistic understanding of disease-promoting artery wall LDL entry now in hand,
interventions inhibiting the process may represent a new therapeutic category in the battle
against cardiovascular disease.
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METHODS
Animal Models
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Experiments were performed in male and female wild-type, apoE−/−, LDLR−/−, SR-B1fl/fl,
PDZK1fl/fl, VECad-Cre and Alb-Cre mice, or in offspring from their mating. The targeting
construct to create floxed SR-B1 mice (SR-B1fl/fl) contained loxP sites inserted in intron 1
and intron 3 of the Scarb1 gene. The heterozygous SR-B1fl/+ mice initially created on mixed
background were crossed with apoE−/− and VECad-Cre mice to generate
hypercholesterolemic littermates expressing versus deficient in SR-B1 in endothelium (apoE
−/−;SR-B1fl/fl versus apoE−/−;SR-B1fl/fl;VECad-Cre designated apoE−/−;SR-B1ΔEC), and
these were employed in the initial studies of atherosclerosis. The heterozygous SR-B1fl/+
mice were also backcrossed to C57BL/6 for more than eight generations, with resulting mice
on C57BL/6 background used in experiments that followed. With additional matings LDLR
−/−;SR-B1fl/fl versus LDLR−/−;SR-B1fl/fl;VECad-Cre designated LDLR−/−;SR-B1ΔEC were
also produced. The present use of SR-B1ΔEC for receptor loss-of-function in endothelium
contrasts with previous gain-of-function studies performed in mice harboring a Tie2-driven
SR-B1 transgene28. In that work SR-B1 overexpression yielded atheroprotection. However,
the transgene caused a decline in plasma cholesterol and a 50% increase in HDL, and since
Tie2-driven gene expression occurs in hematopoietic lineages and endothelium29, nonendothelial processes cannot be excluded. We also crossed SR-B1ΔEC with Alb-Cre mice
(B6.Cg-Tg(Alb-Cre)21Mgn/J, Jackson Laboratory)30 to generate mice deficient in SR-B1 in
hepatocytes, designated SR-B1ΔHEP. The targeting construct to create floxed PDZK1 mice
(PDZK1fl/fl), which contained lox P sites inserted in intron 1 and intron 4, was created by
BAC recombineering31. BAC RP23–405I24 containing the mouse PDZK1 gene was kindly
provided by the Children’s Hospital Oakland Research Institute (CHORI). The heterozygous
PDZK1fl/+ mice initially produced were backcrossed to C57BL/6 for more than eight
generations before crossing with apoE−/− and VECad-Cre for studies of endothelial PDZK1
in apoE−/−;PDZK1fl/fl versus apoE−/−;PDZK1fl/fl;VECad-Cre mice, designated apoE
−/−;PDZK1ΔEC. The cell specificity of SR-B1 or PDZK1 knockdown was evaluated by
quantitative RT-PCR or immunoblotting in primary aortic endothelial cells32 versus myeloid
lineage cells purified from bone marrow using anti-CD11b and anti-Gr-1 antibodies (BD
Biosciences). Effective excision of the genes in endothelium was also demonstrated by PCRbased genotyping on aortas with versus without intact endothelium. In select experiments
LDLR was downregulated in the liver by an IV injection of AAV8-PCSK9 (5×1011gc/
mouse). All mice were maintained on standard chow. In studies of atherosclerosis, beginning
at weaning at age 4 weeks apoE−/−mice received an atherogenetic diet (D12108C, 20% fat,
1.25% cholesterol, Research Diets Inc.) for 8 weeks, LDLR−/− were fed TD96335 (6.2% fat,
1.25% cholesterol, Harlan Laboratories) for 12 weeks, or following AAV8-PCSK9 injection
at 4–5 weeks of age, mice received TD96335 for up to 12 weeks. All animal experiments
were approved by the Institutional Animal Care and Use Committee at UT Southwestern.
Atherosclerosis Evaluation and Lipid Analyses
Atherosclerotic lesions were evaluated as previously described33. Mice were anesthetized
with isoflurane, blood was collected for lipid analyses, and the vascular system was perfused
with normal saline administered by left ventricle puncture. Adventitial fat was removed from
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the aortic arch prior to in situ imaging. The heart and whole aorta were isolated and placed
in 10% formalin for fixation overnight, the heart was dehydrated in 30% sucrose at 4°C
overnight and embedded in OCT compound (Fisher Healthcare), and serial frozen sections
(8um) of the aortic root were obtained. Ten to fifteen slides with 6 sequential sections each
were prepared from each heart, and 1–2 slides per heart were processed for Oil Red O
staining of the aortic sinus. For en face analysis, the entire aorta from the aorta root through
the bifurcation of the iliac arteries was stained with Oil Red O for 2h at room temperature,
adjoining tissues were removed, and the aorta was opened longitudinally and pinned onto a
black silicon bed. Lesion quantification was evaluated by morphometry of obtained images
using Photoshop software.
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Plasma total cholesterol and triglyceride concentrations were determined by colorimetric
enzymatic assay (Infinity, Thermo Scientific). HDL levels were determined by precipitating
apoB-containing lipoproteins using phosphotungstate-magnesium and measurement using
the HDL Cholesterol Kit (Wako)34. Plasma lipid profiles were obtained by column
fractionation and measurements of fraction cholesterol content35.
Cardiac Phenotyping
Using previously-described methods8, hearts were excised and rinsed in PBS and fixed in
10% formalin for 48h, embedded in paraffin, and sectioned at 5um intervals. Hematoxylin
and eosin staining and Masson’s trichrome staining were performed following standard
procedures. Macrophage content was evaluated by immunohistochemistry using anti-CD68
antibody (ab955, Abcam). Survival curves were generated to compare the overall outcome
of SR-B1fl/fl controls and SR-B1ΔHEP that were made hypercholesterolemic with AAV8PCSK9.
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In Vivo Leukocyte-endothelial Adhesion and Endothelial Permeability
Leukocyte-endothelial adhesion was assessed using our previously-established method35.
Briefly, in 4- to 5-week-old male mice, endogenous leukocytes were fluorescence labeled by
injection with 100ul Rhodamine-6G (0.05% w/v) via optic vascular plexus. Under
anesthesia the mesentery was exposed on a clear dish for the observation and recording of
images of leukocyte adhesion and rolling in the mesenteric microvasculature using a Regita
digital camera (400x magnification; QImaging). The velocity of leukocyte rolling was
calculated using Image-Pro V.6.2 (Media Cybernetics). To evaluate adhesion under both
control and pro-inflammatory conditions, mice received an IP injection of normal saline or
TNFα (0.3ug/mouse) 4h prior to study.
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To evaluate endothelial permeability, mice were injected retro-orbitally with 0.5% (w/v)
Evans blue dye dissolved in normal saline (4ul/g body weight) as described previously36.
After 1h, the mice were euthanized and perfused via the left ventricle with 10ml cold PBS.
The entire aorta was isolated, washed in PBS, and placed in formamide at 55°C for 48h.
Following centrifugation the dye concentration was determined by measuring absorbance at
650nm with comparison to a standard curve.
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Human native LDL (nLDL) was kindly provided by Drs. J. Goldstein and M. Brown (UT
Southwestern). Briefly, LDL particles were isolated by ultracentrifugation from normal
human plasma and stored in buffer containing 0.27mM EDTA at 4°C. To generate oxidized
LDL (oxLDL), nLDL particles at a concentration of 1 mg protein/ml were incubated with
5uM CuSO4 at 37°C for 24h, 100uM EDTA and 20uM butylated hydroxytoluene were
added to terminate oxidation, and the resulting samples were dialyzed with PBS for 48h.
Murine LDL (density 1.019–1.063 g/ml) and VLDL/IDL (density 1.006–1.019 g/ml) was
obtained from pooled LDLR−/− mouse plasma by sequential ultracentrigation37. To optimize
their detection, nLDL, oxLDL or murine LDL or VLDL/IDL were labeled with
1,1’dioctadecyl-3,3,3’,3’-tetramethylindocarbocyanine perchlorate (Dil, Invitrogen) at 37°C
for 16h, centrifuged at 16,000 × g for 10min at 4°C, and dialyzed with PBS for 24h. Dillabeled LDLs were stored at 4°C and used within 1–2 weeks38.
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To evaluate aorta LDL uptake in vivo, following receipt of an atherogenic diet for one week,
8–10 week-old mice were injected retro-orbitally with 100ug Dil-LDL, and 0 to 4h later the
mice were anesthetized and perfused with ice-cold PBS for 5min, and the thoracic aorta was
isolated. Following removal of the adventitia, the aorta was digested in RIPA buffer (Thermo
Fisher) containing protease inhibitor cocktail (P8340, Sigma), and DiI-labeled lipoprotein
content was quantified either using a fluorometer (POLARstar Omega, BMG LABTECH)
and measurement of aorta homogenate protein content (Pierce BCA Protein Assay Kit), or
when human LDL was employed, by immunoblotting with anti-human apoB antibody
(MA5–15851, ThermoFisher) and anti-calnexin antibody (ADI-SPA-860-F, Enzo Life
Sciences) to assess protein loading. To test the impact of a pharmacologic intervention
targeting SR-B1, in select experiments the mice received either control sera or SR-B1
blocking antibody (1:2 dilution, 200ul)39 both16h and 1h prior to the administration of DiILDL.
To visualize LDL transport across the endothelial monolayer in vivo, 4h following
intravenous DiI-LDL administration the aorta was isolated, subjected to Hoechst staining
(5ug/ml) at 4°C for 30min to identify nuclei, washed X3, and then fluorescence confocal
microscopy was performed on the luminal surface using a 20X objective and a Zeiss
LSM710 NLO two-photon excitation microscope. The methods were adapted from
approaches employed to image the brain vasculature of mice40. A minimum of three
randomly-selected regions in the ascending aorta were imaged per mouse to a depth of
approximately 50μm (Z=1–2μm), and the data obtained were analyzed by Zeiss ZEN
software.
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To quantify LDL uptake by arterial wall macrophages/foam cells, 4h following intravenous
DiI-LDL administration, CD45+, F4/80+ cells were isolated from the aorta using our
established approach41. The aorta was digested with liberase TH (4 U/ml, Roche),
deoxyribonuclease (DNase) I (0.1 mg/ml, Sigma), and hyaluronidase (60 U/ml, Sigma) at
37°C for 2h, and flow cytometry (BD Biosciences LSR II) was performed with 1:200
dilutions of anti-CD45 (clone 30-F11) and anti-F4/80 (clone BM8) antibodies obtained from
Biolegend as well as detection of Di-I signal. Data obtained were analyzed using FlowJo
software (Treestar).
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The subcellular localization of intravascularly-administered LDL particles and SR-B1 in
aortic endothelial cells was evaluated by electron microscopy (EM). Following fasting for
4h, 10 week-old C57BL/6 mice were anesthetized and the aorta was cleared of blood in situ
by perfusion with PBS with 0.25% glucose at 37°C. The thoracic aorta was then perfused
(15ml/min) with colloidal gold-labeled nLDL (10–15nm diameter, 50ug/ml in EBM2
medium plus 1%BSA, 37°C)42, 43 from proximal to distal, and the perfusate was
recirculated. Ten minutes later the thoracic aorta was washed with ice-cold PBS (10 ml) to
remove unbound LDL, harvested and opened longitudinally, and incubated in EM fixation
solution (4% PFA in 0.1M phosphate buffer pH7.4, containing 0.1% glutaraldehyde) for
30min at room temperature. SR-B1 was visualized using a primary antibody to mouse SRB1 (Novus, NB400–104)44 and a fluoronanogold (1.4nm diameter)-conjugated secondary
antibody (Alexa Fluor 488-FluoroNanogold Fab’ goat anti-rabbit IgG, 7204, Nanoprobes).
The immunogold-labeled samples were further gold-enhanced for 2.5 min using a gold
enhancement kit (Nanoprobes). After washing with water and 0.1M cacodylate buffer,
samples were fixed with 1% OsO4 and 0.8% potassium ferricyanide in 0.1M cacodylate
buffer for 1h, stained en bloc with 2% aquaous uranyl acetate, dehydrated with increasing
concentration of ethanol, and embedded in Epon. Blocks were sectioned with a diamond
knife (Diatome) on a Leica Ultracut 7 ultramicrotome (Leica Microsystems) and collected
onto copper grids. Images were acquired on a JOEL 1400 Plus transmission electron
microscope equipped with a LaB6 source using a voltage of 120 kV, and the images were
captured by an AMT BIOSPRINT 16M-ActiveVu mid mound CCD camera. In sections
processed in the absence of primary anti-SR-B1 antibody, the gold particles detecting SR-B1
were absent.
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Cultured Cell Models, Gene Silencing and Reconstitution
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Primary human aortic endothelial cells (HAEC) obtained from Lonza were maintained in
EBM2 medium with 10% (v/v) fetal bovine serum and studied at passage 3 to 6. Gene
silencing was accomplished using predesigned and validated siRNAs targeting SR-B1
(s2648), PDZK1 (s10282), LOX1 (s9842), LDLR (S224006), or CD36 (s534752) (Life
Technologies Corp.), and effective knockdown was confirmed by immunoblot analysis.
ALK1 was silenced using shRNA (TRCN0000000354) (Sigma), and successful loss of
ALK1 was confirmed by quantitative RT-PCR and measurement of SMAD1/5 Ser463/465
phosphorylation in response to BMP9 treatment (10ng/ml) for 0 to 120 min19. In studies of
DOCK4, gene silencing was done with a lentiviral shuttle plasmid for shRNA targeting
human DOCK4 (TRCN0000288692) (Sigma). In select studies including the experiments
determining the SR-B1 structural features required for LDL transport, the endogenous
receptor was knocked down by shRNA targeting the 3’UTR of the human SR-B1 gene (5’CCGGGCTCGTCAACAAGCACTGTTCCTCGAGGAACAGTGCTTGTTGACGAGCTTT
TTG-3’ in pLKO.1-TRC). Wild-type or mutant forms of SR-B1 were reintroduced using
CMV promoter-driven lentiviral constructs. Polybrene (8ug/ml, EMD Millipore) was added
to the medium to enhance lentiviral transduction efficiency, and experiments were performed
48h later. The SR-B1 mutants were generated using cDNA encoding human Scarb1
(NM_005505, Sino Biological Inc.) and the Virapower Lentiviral Expression System
(ThermoFisher). Shuttle plasmid (5ug), psPAX2 packaging plasmid (3ug), and pMD2.G
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envelope plasmid (2ug) were co-transfected into HEK-293FT cells in DMEM using
Fugene6. Six hours and 48h post-transfection, the medium was replaced with DMEM
containing 2mM caffeine and 30% FBS. The lentiviral particles were harvested 48h and 72h
after transfection, passed through a 0.45um filter (Millipore) to remove cellular debris,
concentrated by ultracentrifugation at 100,000 × g for 90min at 4°C, and resuspended in
Dubelcco’s phosphate-buffered saline (Gibco) overnight at 4°C. The lentiviral preparations
were then aliquotted and stored at −80°C, and SR-B1 mutations were confirmed by
sequencing.
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Total cell abundance of the reconstituted wild-type or mutant forms of SR-B1 was evaluated
by immunoblot analysis 48h following lentiviral transduction. To assess their cell surface
abundance, cells were incubated with anti-SR-B1 antibody directed against the extracellular
domain (NB400–134, Novus Biologicals) on ice for 30min, washed X3, incubated with
alexa488-conjugated secondary antibody for 30min at 4°C, washed X3, and subjected to
flow cytometry (BD Biosciences LSR II).
Quantitative RT-PCR
Transcript abundance was evaluated in mouse aorta, mouse aortic endothelial cells or human
endothelial cells by quantitative RT-PCR using previously established methods35.
LDL Binding, Uptake and Transcytosis
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To evaluate DiI-LDL binding, cells in 24-well plates were precooled at 4°C for 10min,
incubated with 50 ug/ml DiI-LDL at 4°C for 10 min, washed X3 with ice-cold PBS and
lysed in 1% Triton X100 at room temperature for 10min with shaking, and fluorescence was
quantified using a fluorometer (POLARstar Omega, BMG LABTECH) and normalized to
total protein content.
LDL uptake studies entailed cell incubation with 10ug/ml DiI-LDL for 4h at 37°C. In select
experiments the DiI-LDL incubation followed a 1h preincubation with DMSO control
vehicle versus the SR-B1 inhibitor BLT-1 (10uM, Sigma)45, or control unrelated IgG versus
anti-SR-B1 blocking antibody. DMSO control had no effect on LDL transport. Cells were
washed with PBS and lysed for the measurement of fluorescence intensity by fluorometer.
For imaging of LDL uptake, experiments were performed with cells seeded onto glass
coverslips precoated with collagen I. Following DiI-LDL incubations the cells were fixed
with 1% formalin in PBS for 10min at room temperature, nuclei were stained with DAPI,
mounting media was added (Vector Laboratories, Inc.), and fluorescence microscopy was
performed at 40X magnification with a Nikon Eclipse TE2000-E microscope.
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LDL transcytosis was studied using approaches derived from previously-reported
methods32. Cells were seeded twice, 24h apart, onto 0.4um pore PET Transwell inserts
(3610, Corning, Inc.) coated with collagen I (BD Bioscience), with or without lentiviral
transduction overnight. Transcytosis was evaluated 48h later, at which time measurements of
transepithelial electrical resistance using an epithelial volt-ohmmeter (World Precision
Instruments) confirmed the establishment of a confluent monolayer. FITC-dextran (M.W.
3000; Invitrogen) was used to assess paracellular transport. Cells were incubated
simultaneously for 2h with FITC-dextran and 50ug/ml Dil-LDL added to the upper chamber,
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and the fluorescence intensity of FITC and Dil in the lower chamber was measured using a
fluorometer (POLARstar Omega, BMG LABTECH). FITC-dextran transport was 2 to 3%
and similar for control cells and cells in which SR-B1 expression was reconstituted.
Infrequently-observed inserts displaying paracellular transport more than 5% were
discarded. The addition of 50-fold excess LDL decreased the DiI signal for transcytosis by
75%. In select experiments interventions were placed in the upper chamber for 1h prior to
the addition of DiI-LDL. Under control conditions the percent transcytosis of DiI-LDL was
approximately 12%, and the data shown are normalized to control values. HDL transcytosis
was also performed using DiI-labeled lipoprotein. The validity of the uptake and transcytosis
assays employing DiI-LDL was confirmed using nLDL labeled with iodine-125 by the
Bolton-Hunter method. In uptake studies, cells were incubated with 10ug/ml 125I-LDL for
4h, washed with PBS and lysed with 0.1N NaOH, and radioactivity was quantified in the
cell lysate using a Wizard Automatic Gamma Counter (PerkinElmer) and expressed relative
to protein content. For transcytosis studies, cells were incubated with 50ug/ml 125I-LDL for
2h and radioactivity in both the upper and lower chambers was quantified.
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To provide an additional means to confirm the findings obtained for transcytosis, total
internal reflection fluorescence (TIRF) microscopy was employed10, 19. Time-lapse imaging
of transcytosis was carried out on an OMX SR microscope in Ring TIRF mode (GE
Healthcare Life Science). Briefly, endothelial cells seeded in 35 mm glass bottom dishes
(MatTek, MA) were treated with 50μg/ml Dil-nLDL in EGM2 medium with HEPES at 4°C
for 10 min to allow the LDL to bind to the apical cell surface without internalization.
Endothelial cells pretreated with Dyngo4A (30μM; Abcam) for 30 min were processed in
parallel to confirm dynamin dependence of transcytotic events10. The cells were rinsed with
cold PBS, and warm medium was added, and the dish was placed in a 37°C live cell
incubation chamber on the microscope stage for 2 min before imaging. An Olympus ApoN
60× 1.49 NA lens was used for through the objective TIRF with 561 nm laser excitation. The
TIRF angle was set at 96% of the back aperture of the lens, for an estimated nominal
penetration depth of 70 nm. Images were acquired using a cooled sCMOS camera with a 50
ms exposure at 150 ms intervals for a minimum of 40 sec. At least 15 randomly-selected
cells were imaged for each condition, and the transcytosis events in the first 5 to 6 cells
imaged were quantified using Imaris 9.2.0. image analysis software (Bitplane, Zurich
Switzerland). The Spots Wizard was used to identify DiI-labeled LDL particles and track
them over time. The spots were filtered based on mean squared displacement over time to
exclude those exhibiting Brownian motion or active transport, and statistics measured by
Imaris were exported for analysis in Excel. Numbers of transcytosis events captured in 200
frames were determined using criteria reported previously19.
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NOS Assays
To assess caveolae function in cultured endothelial cells, the conversion of 14C-L-arginine to
14C-L-citrulline was measured in intact cells under basal conditions or with the addition of
VEGF (100ng/ml) or HDL (20ug/ml)46. In select studies caveolae were disrupted by cell
treatment with methyl-β-cyclodextrin (10mM for 60min) prior to the evaluation of NOS
activation.
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Liquid Chromatography/Tandem Mass Spectrometry (LC/MS-MS)
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To identify proteins that interact with SR-B1 in endothelial cells, SR-B1
immunoprecipitation was facilitated by N-terminal HIS tagging of the receptor. N-terminal
tagging was chosen because the SR-B1 N-terminal tail does not participate in any known
function of the receptor47, and the addition of the N-terminal HIS tag did not affect LDL
uptake by SR-B1 in HAEC (data not shown). An N-terminal HIS tag was also placed on the
SR-B1-ΔC23 truncated form of the receptor. Endogenous SR-B1 was silenced in HAEC,
receptor expression was reconstituted with either HIS-SR-B1 or HIS-SR-B1-ΔC23, SR-B1
was immunoprecipitated with anti-HIS antibody, and the associated proteins were evaluated
by liquid chromatography/tandem mass spectrometry (LC/MS-MS). Immunoprecipitated
protein samples were electroporated 10mm into the top of a pre-cast SDS-PAGE gel (BioRad), stained with Coomassie blue and excised. Following alkylation and reduction with
dithiothreitol and iodoacetamide (Sigma), samples were digested overnight with trypsin
(Promega) and then subjected to LC/MS-MS using a QExactive mass spectrometer (Thermo
Electron) coupled to an Ultimate 3000 RSLC-Nano liquid chromatography system (Dionex).
Peptides were loaded onto a 180μm i.d., 5cm long, self-packed column containing 1.9μm
C18 resin (Dr. Maisch, Ammerbuch, Germany) and eluted with a gradient of 0–40% buffer
containing 80% (vol/vol) ACN, 10% (vol/vol) trifluoroethanol, and 0.08% formic acid for 60
min. Up to 10 high-energy, collision-induced dissociation fragment spectra were obtained
for each full spectrum acquired. Raw MS data files were converted to peak list format using
ProteoWizard Msconvert, and the resulting files were analyzed using the Central Proteomics
Facilities Pipeline48. Label-free quantitation of proteins across samples was performed using
the Normalized Spectral Index method (SINQ)49.
Co-immunoprecipitation and Immunoblot Analyses
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Co-immunoprecipitation studies were performed to evaluate proteins interacting with either
HIS-tagged wild-type or mutant SR-B1, or DOCK4 in HAEC. Cells were incubated with
lysis buffer containing 25mM Tris-HCl, pH7.4, 150mM NaCl, 1% NP-40, 1mM EDTA, and
5% glycerol (Thermo Fisher) supplemented with protease inhibitor cocktail (P8340, Sigma)
on ice for 1h with vortexing every 20min. Supernatants collected following centrifugation at
14,000 × g at 4°C for 10 min were incubated with control IgG, anti-DOCK4 (ab85723,
Abcam) or anti-HIS tag (ab18184, Abcam) antibody at 4°C overnight, and protein A/G plus
agarose beads (Pierce) were added for 2h. The beads were pelleted by centrifugation,
washed X3, and the bound proteins were eluted with SDS sample buffer and analyzed by
SDS-PAGE and immunoblotting. Primary antibodies employed were anti-DOCK4 antibody,
and anti-SR-B1 antibody recognizing the N-terminus (ab52629, Abcam) to identify Cterminally-truncated SR-B1. HRP-conjugated secondary antibodies and chemiluminescent
detection and densitometry were then employed.
In cell culture experiments additional immunoblot analyses were performed employing antiSR-B1 (NB400–113 and NB400–134,Novus; ab52629, Abcam), anti- PDZK1 (ab64856,
Abcam), anti-LOX-1(MAB1798, R&D Systems), anti-LDLR (AF2148, R&D Systems),
anti-CD36 (NB400–144,Novus; MA-5–14112, Invitrogen) and anti-transferrin receptor
(ab84036, Abcam) antibodies. Protein loading was assessed using anti-GAPDH (sc-365062,
Santa Cruz) antibody.
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Gene Expression Profiling in Human Atherosclerotic versus Normal Arteries
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To compare SR-B1 and DOCK4 in human atherosclerotic versus normal arteries, three
publicly available independent human atherosclerosis cohorts with gene expression data
were downloaded from Gene Expression Omnibus (GEO, https://www.ncbi.nlm.nih.gov/
geo/). The accession numbers were GSE116243, GSE40231, and GSE43292. For the
GSE116243 cohort (Cohort I), which included atherosclerotic aortic lesions, the gene
expression profiling was generated by RNA sequencing through Illumina HiSeq 2500. For
comparison, RNA sequencing datasets of aorta from healthy donors were downloaded from
Genotype-Tissue Expression (GTEx) database with accession number phs000424.v6.p1.
RNA-seq reads from FASTQ files were quality-filtered using FASTQ Quality Filter (-q 20 –
p 75) from FASTX-toolkit (http://hannonlab.cshl.edu/fastx_toolkit/). The filtered reads were
then aligned to hg38 reference genome by HISAT2 aligner50. Cufflinks51 was used to
assemble and estimate the relative abundances of transcripts at the gene and transcript level.
For the GSE40231 cohort (Cohort II), which compared atherosclerotic aortic lesions with
internal mammary artery from the same subjects, gene expression profiling was generated by
Affymetrix Human Genome U133 Plus 2.0 Array. Signal intensity CEL files were
downloaded from GEO and then processed by Affymetrix Power Tools (APT) with Robust
Multiarray Average (RMA) method. For the GSE43292 cohort (Cohort III), which matched
atherosclerotic carotid artery with healthy carotid artery from the same subject, gene
expression profiling was generated by Affymetrix Human Gene 1.0 ST Array. CELL files
were downloaded from GEO and then were analyzed using R/BioConductor package with
RMA method and custom PERL scripts. Data are presented as box-and-whisker plots, with
the central lines denoting medians, edges of the box representing upper and lower quartiles,
and whiskers showing minimum and maximum values after excluding outliers outside 1.5
times the interquartile range. Notably although the analyses of the three cohorts utilized
distinct technology platforms to measure gene expression, the same findings were obtained.
SR-B1 Internalization
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To evaluate SR-B1 internalization, following surface protein labeling with 2mM Sulfo-NHSSS-biotin at 4°C for 30min33, the cells were washed with 100mM glycine in PBS to quench
non-reacted biotinylation reagent, and then incubated with 50 ug/ml Dil-LDL at 37°C for 0
to 10min. Remaining cell surface biotin was cleaved with 50mM reduced glutathione
(Sigma), cells were lysed in RIPA buffer, biotinylated proteins were isolated by incubating
with streptavidin magnetic beads overnight at 4°C, the bound proteins were eluted with
loading buffer, and immunoblot analysis was performed. To assess the efficacy of SR-B1
biotinylation, whole cell lysates were obtained at 0 to 10min of incubation, and total
biotinylated SR-B1 was quantified by immunoblotting. To evaluate the internalization of
another cell surface protein, the abundance of internalized transferrin receptor and total
biotinylated transferrin receptor was determined in a parallel manner.
Rac1 Activity Assay and Rac1 Loss-of-function
Rac1 activity was evaluated by affinity purification and immunoblotting (Millipore).
Following cell treatment, cell lysates were incubated with PAK1 PBD agarose to bind
activated, GTP-bound Rac1, and its abundance was determined by immunoblotting. Total
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Rac1 in cell lysates was also evaluated by immunoblotting. To determine the role of Rac1 in
endothelial cell LDL uptake, cells were transduced with adenovirus encoding GFP or a
dominant-negative form of Rac1 (T17N)52 with MOI 100 for 48h prior to the uptake assay.
The impact of pharmacologic inhibition was also tested, pretreating cells with vehicle or the
Rac1 inhibitor NSC23766 (100uM)53 for 1h prior to the uptake assay.
Statistics and Reproducibility
Results are expressed as mean±SEM. Comparisons between two groups were done by twosided Student’s t test unless otherwise noted, and analysis of variance (ANOVA) with
Dunnett’s post-hoc testing was performed to compare 3 or more groups. A p value <0.05
was considered statistically significant. When representative findings are presented, similar
results were obtained at least three times. Observations in cell culture were confirmed in
three independent experiments.
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Extended Data Figure 1. Establishment of mice lacking endothelial SR-B1 or PDZK1.
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a,j, Schematics of the gene-targeting strategies to generate floxed alleles of Scarb1 (a) and
PDZK1 (j) to create SR-B1fl/fl and PDZK1fl/fl mice. In SR-B1fl, exon 2 was floxed, and in
PDZK1fl, exons 2 and 3 were floxed. The recombined alleles following Cre recombinase
introduction are also shown. b,k, Using primers depicted in a and j, PCR-based genotyping
was performed on aortas with versus without intact endothelial cells (EC). Aortas were
obtained from floxed mice, and mice with Scarb1 or PDZK1 deleted selectively from EC
(SR-B1ΔEC or PDZK1ΔEC). In genotyping evaluating Scarb1 excision (b), additional
samples were obtained from SR-B1fl/fl mice expressing Cre recombinase globally (gCre). In
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genotyping evaluating PDZK1 excision (k), lung samples were also studied. c,l, Quantitative
real-time PCR analysis of SR-B1 (c) or PDZK1 expression (l) in primary aortic EC (n=6)
and bone marrow-derived myeloid lineage cells (n=5). d,e,f, SR-B1 protein abundance (d,e,
n=4) and ALK1 transcript levels (f, n=4) were evaluated in aortic endothelial cells from SRB1fl/fl and SR-B1ΔEC mice; summary data for SR-B1 protein are in e. The uncropped
versions of all immunoblots shown are provided in Supplementary Figure 1. g,m,
Immunoblotting of SR-B1 (g) or PDZK1 protein (m) abundance in liver. h,n, Plasma
cholesterol levels. For SR-B1 studies, n=4,3,9 and 10 mice, respectively, for PDZK1 studies,
n=4, 3, 6 and 6 mice, respectively. i,o, Representative lipoprotein profiles. Data are mean
±SEM; in c, e, and I, P values by two-sided Student’s t test are shown, and in h and n, P
values by ANOVA with Dunnett’s post hoc testing are shown.
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Extended Data Figure 2. Atherosclerosis is promoted by endothelial SR-B1 but not by
endothelial PDZK1, and neither endothelial SR-B1 nor PDZK1 affect circulating lipids.

Findings are shown for SR-B1 in mixed background females (a-g) and in C57BL/6 males
(h-n), and for PDZK1 in C57BL6 males (o-u). Representative in situ aortic arch images of
atherosclerotic plaque (yellow arrows) are in a, h and o, representative images for lipidstained lesions in en face aortas are in b, i and p, and representative images for lipid/
hematoxylin-stained aortic root sections (lesions outlined by yellow dashed line,
magnification 40X) are in d, k and r. Lesion area quantitation in en face aortas (percent total
surface area) are in c (n=13 and 14, respectively), j (n=10 and 9, respectively) and q (n=14/
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group), and quantitation in aortic root sections are in e (n=9/group), l (n= 10 and 9,
respectively) and s (n=10 and 11, respectively). Plasma total cholesterol (TC), triglyceride
(TG), and HDL cholesterol (HDL-c) are in f (n=12/group for TC and TG, and 10/group for
HDL-c), m (n=16 and 9, respectively for TC and TG, and n=10 and 9, respectively for HDLc), and t (n=14/group for TC and TG, and 10/group for HDL-c); findings for SR-B1fl/fl, SRB1ΔEC and PDZK1ΔEC are shown in blue, red and orange, respectively. Representative
lipoprotein profiles are in g, n and u. Data are mean±SEM. In c, e, j and l, P values by twosided Student’s t test are shown.

Author Manuscript
Author Manuscript
Author Manuscript
Nature. Author manuscript; available in PMC 2019 October 24.

Huang et al.

Page 19

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

Extended Data Figure 3. Endothelial SR-B1 promotes atherosclerosis in LDLR null mice by
driving LDL entry into the artery wall.

a, Representative in situ aortic arch images of atherosclerotic plaque (yellow arrows) in male
LDLR−/−;SR-B1fl/fl and LDLR−/−;SR-B1ΔEC mice. b, Representative lipid-stained en face
images of aortas. c) Quantitation of lesion areas in en face aortas (percent of total surface
area); n=10 and 8, respectively. d, Representative lipid/hematoxylin-stained aortic root
sections (lesions outlined by yellow dashed line, magnification 40X). e, Quantitation of
lesion areas in aortic root sections; n=10 and 8, respectively. f-h, Plasma total cholesterol (f),
triglyceride (g), and HDL cholesterol (h), n=10 and 8, respectively. i, Representative
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lipoprotein profiles. j,k, Aorta dil-nLDL uptake. Human apolipoprotein B abundance (j) or
Dil fluorescence intensity (k) was evaluated in aorta homogenates 4h following IV DiInLDL injection. Left panel in j displays a representative immunoblot with 3 samples per
group, and in j and k, n= 5/group. l,m, Aorta dil-labeled mouse LDL (l) or mouse
VLDL/IDL (m) uptake in LDLR−/−;SR-B1fl/fl and LDLR−/−;SR-B1ΔEC mice (n=4 and 5,
respectively). Data are mean±SEM, P values by two-sided Student’s t test are shown.
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Extended Data Figure 4. Endothelial SR-B1 and hepatocyte SR-B1 have opposing impact on
atherosclerosis.

Using AAV8-PCSK9, hypercholesterolemia was induced in male SR-B1fl/fl mice, and in SRB1ΔEC or SR-B1ΔHEP mice lacking SR-B1 selectively in endothelial cells or hepatocytes,
respectively. Findings in SR-B1fl/fl versus SR-B1ΔEC are in a-l, and findings in SR-B1fl/fl
versus SR-B1ΔHEP are in m-v. a, Representative in situ aortic arch images of atherosclerotic
plaque (yellow arrows) in SR-B1fl/fl and SR-B1ΔEC mice. b, Representative lipid-stained en
face images of aortas. c) Quantitation of lesion areas in en face aortas (percent of total
surface area); n=12 and 10, respectively. d, Representative lipid/hematoxylin-stained aortic
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root sections (lesions outlined by yellow dashed line, magnification 40X). e, Quantitation of
lesion areas in aortic root sections; n=10 and 9, respectively. f-h, Plasma total cholesterol (f),
triglyceride (g), and HDL cholesterol (h), n=12 and 11, respectively. i, Representative
lipoprotein profiles. j,k, Aorta dil-nLDL uptake. Human apolipoprotein B abundance (j) or
Dil fluorescence intensity (k) was evaluated in aorta homogenates 4h following IV injection
(n=6 and 5, respectively). Left panel in j displays a representative immunoblot with 3
samples per group. l, LDLR abundance in livers of control mice and SR-B1fl/fl and SRB1ΔEC mice administered AAV-PCSK9. Immunoblot depicts protein abundance for 2
samples per group. m, Survival curves for SR-B1fl/fl and SR-B1ΔHEP mice, n=5 and 4,
respectively. n, Representative lipid-stained en face images of aortas. o, Quantitation of
lesion areas in en face aortas. Aortas and plasma were only available from two SR-B1ΔHEP
mice. p, Longitudinal sections of SR-B1fl/fl and SR-B1ΔHEP hearts stained with H&E or
trichrome (healthy myocardium, red/brown; fibrotic tissue, blue; yellow asterisks and arrows
indicate areas of severe fibrosis). Images shown mirror those obtained in all 3 hearts per
group that underwent histological analysis. q. Coronary arteries of SR-B1fl/fl and SRB1ΔHEP mice stained with H&E or trichrome, and coronary artery of SR-B1ΔHEP mouse
stained with anti-CD68 to detect macrophages. r-t, Plasma total cholesterol (TC),
triglyceride (TG), and HDL cholesterol (HCL-c). u, Representative lipoprotein profiles. v,
Immunoblotting of SR-B1 abundance in liver, showing findings for 2 samples per group.
Data are mean±SEM, P values by two-sided Student’s t test are shown.
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Extended Data Figure 5. Endothelial SR-B1 does not influence vascular inflammation.
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a, Quantitative real-time PCR was performed to compare CD68 transcript levels in aortas
from apoE−/−;SR-B1fl/fl and apoE−/−;SR-B1ΔEC male mice, n=8/group. b-i, mRNA
abundance was also evaluated for the following genes, using HPRT1 as a housekeeping gene
and normalizing expression to CD68 levels: E-selectin (b), P-selectin (c), VCAM-1 (d),
ICAM-1 (e), TGFβ (f), TNFα (g), IL-6 (h), and IL-10 (i), with n=8/group. j, Representative
still images of leukocyte-endothelial cell adhesion evaluated by intravital microscopy in the
mesenteric microcirculation of apoE−/−;SR-B1fl/fl and apoE−/−;SR-B1ΔEC male mice
administered vehicle (n=10 and 11, respectively) or TNFα (n=5 and 6, respectively). k,
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Summary data for leukocyte velocity in four study groups in j. l, Gating strategy for
evaluation of CD45+, F4/80+ cell number and DiI-LDL uptake in the aorta. Following
digestion of the aorta, all cells were first gated in FSC/SSC according to cell size and
granularity. The resulting population was gated according to cell viability using DAPI.
DAPI- live cells were gated for positivity for CD45, and CD45+ cells were then gated for
positivity for F4/80 and the DiI label. Data are mean±SEM; in k, P values by ANOVA with
Dunnett’s post-hoc test are shown.
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Extended Data Figure 6. Endothelial SR-B1 drives both nLDL and oxLDL delivery into the
artery wall.

a, Three-dimensional depiction of Dil-oxLDL localization determined by confocal
fluorescence microscopy of the luminal surface of the ascending aorta of apoE−/−;SR-B1fl/fl
and apoE−/−;SR-B1ΔEC mice. Lumen is on the left. DiI is shown in red and Hoechst staining
of nuclei is shown in blue. b, Representative cumulative images of the X-Y plane parallel to
the luminal surface. c, Summation of dil-oxLDL signal in the superficial ascending aorta.
Two areas encompassing at least 100 cells were counted per mouse in 3 mice per group for
total n=6/genotype group. d,e, Aorta dil-oxLDL uptake. Human apolipoprotein B abundance
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(d) or Dil fluorescence intensity (e) was evaluated in aorta homogenates 4h following IV
DiI-oxLDL injection; n=8/group. f,g, Using same approaches as in d and e, aorta dil-oxLDL
uptake was evaluated in apoE−/− mice treated with control Ab or SR-B1 blocking antibody
given IP prior to IV injection of diI-oxLDL (n=6 and 7, respectively). h, Quantification of
CD45+, F4/80+ macrophages in the aorta (n=6/group). Results are expressed relative to
abundance in apoE−/−;SR-B1fl/fl control mice. i, Dil-oxLDL distribution in CD45+, F4/80+
macrophages in the aorta, n=6/group. j,k, Aorta dil-nLDL uptake. Human apolipoprotein B
abundance (j) or Dil fluorescence intensity (k) was evaluated in aorta homogenates 4h
following IV DiI-nLDL injection; n=7 and 8, respectively. l,m, Using same approaches as in
j and k, aorta dil-nLDL uptake was evaluated in apoE−/− mice treated with control Ab or SRB1 blocking antibody given IP prior to IV injection of diI-nLDL (n=5/group). Left panel in
d, f, j and l displays a representative immunoblot with 3 samples per group; Data are mean
±SEM, P values by two-sided Student’s t test are shown. See also Videos 1,2.
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Extended Data Figure 7. Low-power electron micrograph images of LDL-gold and immunogoldlabeled SR-B1 in aortic endothelial cells in vivo.

Following intravascular administration in wild-type mice, gold-labeled LDL particles and
SR-B1 were localized in aortic endothelial cells by electron microscopy. a and b display
images for two different endothelial cells, each bordered by the lumen and elastic lamina.
Shown are the locations of the high-power fields provided in Figure 1n, with LDL-gold
(large particles) highlighted by yellow arrows and immunogold-labeled SR-B1 (small
particles) highlighted by red arrows.
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Extended Data Figure 8. SR-B1 governs endothelial cell LDL transcytosis independent of effects
on caveolae function.

a, Dil-nLDL and diI-oxLDL uptake in endothelial cells after RNAi knockdown of SR-B1 or
PDZK1. In left panel, diI-oxLDL visualization is shown in red, and DAPI-stained nuclei are
in blue. N=6/group. b,c, Dil-nLDL and dil-oxLDL uptake (b) and transcytosis (c) in cells
treated with control IgG or SR-B1 blocking antibody or BLT1. N=6/group. d, Dil-nLDL and
diI-oxLDL transcytosis in endothelial cells after RNAi knockdown of SR-B1. N=3/group.
e,f, NOS activation by VEGF (100ng/ml) or HDL (20ug/ml) with or without RNAi
knockdown of SR-B1 (e, n=10/group) or caveolae disruption by methyl-β-cyclodextrin
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treatment (f, 10mM for 60min, n=8/group). g, Abundance of target protein following RNAi
knockdown of SR-B1, PDZK1, LDLR or CD36 in HAEC. Findings for 3 samples per
condition are shown. In all studies SR-B1, LDLR and CD36 expression were evaluated. h,i,
DiI-nLDL and diI-oxLDL uptake in cells depleted of LDLR by RNAi (h, n=12 for nLDL
and 13 for oxLDL) or treated with control versus LDLR blocking antibody (i, n=6/group). j,
DiI-nLDL and diI-oxLDL transcytosis in cells treated with control versus LDLR blocking
antibody. N=6 for nLDL and 3 for oxLDL. k,l, DiI-nLDL and diI-oxLDL uptake in cells
depleted of CD36 by RNAi (k, n=6/group) or treated with control versus CD36 blocking
antibody (l, n=9 and 12 for nLDL and 6 for oxLDL). m, DiI-nLDL and diI-oxLDL
transcytosis in cells treated with control versus CD36 blocking antibody. N=6/group. Data
are mean±SEM, P values by two-sided Student’s t test (a-c) or by ANOVA with Dunnett’s
post-hoc test (d-f, h-I, k-l) are shown.
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Extended Data Figure 9. Roles of SR-B1, ALK1 and DOCK4 in endothelial cell LDL
transcytosis.

a, Abundance of SR-B1, LDLR, and CD36 protein following RNAi knockdown of SR-B1,
or following reconstitution of wild-type SR-B1 expression in cells depleted of endogenous
receptor. Caveolin-1 (Cav1) expression was also evaluated. Findings for 2 samples per
condition are shown. b, ALK1 transcript levels in cells manipulated as in a. N=4/group. c,
Abundance of SR-B1, LDLR, and CD36 protein following RNAi knockdown of ALK1, SRB1, or ALK1 and SR-B1. Findings for 2 samples per condition are shown. d, ALK1
transcript levels in cells manipulated as in c. N=4/group. e, SMAD1/5 phosphorylation in
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response to BMP9 (10ng/ml, for 0–120 min) following RNAi knockdown of SR-B1 or
ALK1. Abundance of SMAD1/5 Ser463/465 phosphorylation and total SMAD1 were
evaluated by immunoblotting. f, DiI-nLDL transcytosis following RNAi knockdown of
ALK1, SR-B1, or ALK1 and SR-B1. N=9/group. g,h, nLDL uptake was evaluated using
125I-nLDL in the absence or presence of 50-fold excess unlabeled nLDL (g), and h,
following RNAi knockdown of SR-B1 or DOCK4, or reconstitution of wild-type SR-B1
expression in cells depleted of endogenous receptor. N=8/group. i,j, nLDL transcytosis was
evaluated using 125I-nLDL in the absence versus presence of 50-fold excess unlabeled nLDL
(i), and j, following manipulation of SR-B1 or DOCK4 expression as in h. N=3/group. k,l,
nLDL transcytosis was evaluated using total internal reflection fluorescence (TIRF)
microscopy in cells treated with Dyngo4A (k, 30uM) and l, in cells following RNAi
knockdown of SR-B1 or DOCK4. N=6/group. m, Rac1 activation in response to oxLDL was
determined in cells expressing GFP control versus dominant-negative Rac1, and in untreated
cells versus cells incubated with the Rac1 inhibitor NSC23766. Data are mean±SEM, P
values by ANOVA with Dunnett’s posthoc test (d, f, h, j, l) or by two-sided Student’s t test
(g, i, k) are shown.

Author Manuscript
Author Manuscript
Nature. Author manuscript; available in PMC 2019 October 24.

Huang et al.

Page 32

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

Figure 10. Lentiviral reconstitution of wild-type and mutant SR-B1 expression in human
endothelial cells.

a-c, Studies of reconstituted wild-type SR-B1 (WT), extracellular point mutant SR-B1, or
SR-B1-Q445A. The extracellular point mutants were: SR-B1-M159E, T165E, F171A,
T175A, and E178A. Whole cell lysate abundance (a), cell surface abundance (b; except for
Q445A, which was previously evaluated), and nLDL and oxLDL binding (c) were evaluated.
d-f, Studies of reconstituted WT or C-terminal cytoplasmic tail deletion mutant SR-B1. The
mutants were: SR-B1-ΔC15 (Δ495–509), ΔC23 (Δ487–509) and ΔC30 (Δ480–509). Whole
cell lysate abundance (d), cell surface abundance (e), and nLDL and oxLDL binding (f)
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were evaluated. g, Upper Panel: Sequence alignment of amino acids in the C-terminal
cytoplasmic tail of SR-B1 homologs (residues 487–494) from human (Homo sapien, Hs,
Q8WTVO, Swiss-Prot), mouse (Mus musculus, Mm, Q61009, Swiss- Prot), rat (Rattus
norvegius, Rr, P97943, Swiss-Prot), bovine (Bos Taurus, Bt, O18824, Swiss-Prot), pig (Sus
scrofa, Ss, Q8SQC1, Swiss-Prot), and Chinese hamster (Cricetulus griseus, Cg, Q60417,
Swiss-Prot). Fully conserved residues are shown in bold. Lower Panel: Comparison of
human SR-B1 residues 487–494 and entire human CD36 C-terminal cytoplasmic tail.
Residues of SR-B1 not shared with CD36 are shown in bold. h-j, Studies of reconstituted
WT or C-terminal cytoplasmic tail substitution mutant SR-B1. The mutants were: SR-B1IQAY, SESL, Y490A, Q488A, S491A, E492A, S493A, and L494A. Whole cell lysate
abundance (h), cell surface abundance (i), and nLDL and oxLDL binding (j) were evaluated.
k-m, nLDL binding (k), uptake (l) and transcytosis studies (m) were performed with the
various mutants shown at an nLDL concentration of 100ug/ml. n, Whole cell lysate
abundance of CD36 and LDLR was evaluated following reconstitution with the SR-B1
mutants tested in k-m. Data are mean±SEM. For cell surface abundance by flow cytometry,
n=3 or 4. For LDL binding, n=4 or 8. For LDL transcytosis, n=3. In c, k-m, P values for
comparison with WT by two-sided Student’s t test are shown.
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Figure 1. Endothelial SR-B1 promotes atherosclerosis by driving LDL delivery into the artery
wall and uptake by artery wall macrophages.
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a, Representative in situ aortic arch images of atherosclerotic plaque (yellow arrows) in male
apoE−/−;SR-B1fl/fl and apoE−/−;SR-B1ΔEC mice. b, Representative lipid-stained en face
images of aortas. c, Quantitation of lesion areas in en face aortas (percent of total surface
area); n=9 and 16, respectively. d, Representative lipid/hematoxylin-stained aortic root
sections (lesions outlined by yellow dashed line, magnification 40X), e, Quantitation of
lesion areas in aortic root sections; n=9 and 16, respectively. f-h, Plasma total cholesterol (f)
and triglyceride (g, n=9 and 14, respectively), and HDL cholesterol (h, n=7 and 9,
respectively). i, Representative lipoprotein profiles. j, Three-dimensional depiction of DilnLDL localization determined by confocal fluorescence microscopy of the luminal surface
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of the ascending aorta. Lumen is on the left. DiI is shown in red and Hoechst staining of
nuclei is shown in blue. k, Representative cumulative images of the X-Y plane parallel to the
luminal surface. l, Summation of dil-nLDL signal in the superficial ascending aorta. Four
areas encompassing at least 100 cells were counted per mouse in 3 mice per group for total
n=12/genotype group. m, Evaluation of aorta endothelial permeability by quantification of
Evans blue dye incorporation (n=7 and 8, respectively). n, Gold-labeled LDL (large
particles, yellow arrows) and immunogold-labeled SR-B1 (small particles, red arrows) are
colocalized in endothelial cell intracellular vesicles in vivo. Representative images from two
different endothelial cells are shown. o, Quantification of CD45+, F4/80+ macrophages in
the aorta (n=4 and 5, respectively). Results are expressed relative to abundance in apoE
−/−;SR-B1fl/fl control mice. p, Dil-nLDL distribution in CD45+, F4/80+ macrophages in the
aorta; n=4 and 5, respectively. Data are mean±SEM, P values by two-sided Student’s t test
are shown. See also Extended Data Figs. 1a–i, 2–4, 6 and 7.
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Figure 2. SR-B1 mediation of endothelial cell LDL uptake and transcytosis requires LDL
binding to SR-B1 and an 8 amino acid cytoplasmic domain.

a, Schematic of mutant forms of SR-B1 studied by reconstitution in HAEC. b,c, nLDL and
oxLDL uptake (b, n=8 for nLDL and 6 for oxLDL) and transcytosis (c, n=3) by wild-type
(WT) SR-B1 versus LDL binding point mutants or SR-BI-Q445A. d,e, nLDL and oxLDL
uptake (d, n=8 for nLDL and 6 for oxLDL) and transcytosis (e, n=3) by WT SR-B1 versus
C-terminal cytoplasmic tail deletion mutants. f,g, nLDL and oxLDL uptake (f, n=6 or 8) and
transcytosis (g, n=3) by WT SR-B1 versus C-terminal cytoplasmic tail substitution mutants.
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Data are mean±SEM, P values by ANOVA with Dunnett’s post-hoc testing are shown. See
also Extended Data Fig. 10.
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Figure 3. SR-B1 dynamically interacts with DOCK4 in endothelial cells, and their expression is
increased in atherosclerosis-prone regions of mouse aorta prior to lesion formation, and in
human atherosclerotic versus normal arteries.

a, HAEC expressing His-tagged wild-type SR-B1 or SR-B1-ΔC23 were treated with vehicle
or oxLDL, DOCK4 was immunoprecipitated (IP), and immunoblotting was done for
DOCK4 and SR-B1. First IP lane shows IP done with unrelated IgG. b, Same experiment
was performed in HAEC expressing His-tagged wild-type SR-B1, SR-B1-IQAY or SR-B1SESL. c, HAEC reconstituted with His-tagged wild-type SR-B1 were treated with nLDL or
oxLDL, DOCK4 was IP’d and immunoblotting was done for DOCK4 and SR-B1. Summary
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data are for n=4 per group; P values by ANOVA with Dunnett’s post-hoc testing are shown.
d, SR-B1 and DOCK4 expression were evaluated in intact versus endothelium-denuded
mouse aorta by Q-RT-PCR, n=3 arteries per group. e, Left panel: In situ image of aortic arch
from a wild-type, atherosclerosis-free mouse, depicting regions of greater curvature (blue
hashed line) and lesser curvature (red hashed line) sampled for experiment in f. Right panel:
In situ image of aortic arch from apoE−/− mouse with atherosclerotic lesions absent in
greater curvature and present in lesser curvature. f, SR-B1 and DOCK4 expression were
evaluated in greater and lesser curvature samples by Q-RT-PCR, n=4 arteries per group. g-l,
Employing three separate patient cohorts and independent strategies for analyses, SR-B1 (gi) and DOCK4 expression (j-l) were compared in human atherosclerotic versus control
arteries. Cohorts I, II and III contained n=4 and 207, 40 and 40, and 32 and 32, respectively.
Data are mean±SEM; in d and f, P values by two-sided Student’s t test are shown; in g-l,
data are presented as box-and-whisker plots, with the central lines denoting medians, edges
of the box representing upper and lower quartiles, and whiskers showing minimum and
maximum values after excluding outliers outside 1.5 times the interquartile range.
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Figure 4. DOCK4 mediates endothelial cell LDL uptake and transcytosis by internalizing SR-B1
and coupling the receptor to Rac1.

a,b, The internalization of biotinylated SR-B1 and transferrin receptor (TR) was evaluated
following warming from 4°C to 37°C in nLDL- (a) or oxLDL-treated (b) endothelial cells
with normal versus decreased DOCK4 expression. In a-b, n=3/condition and P values by
two-sided Student’s t test are shown. c,d, DiI-nLDL binding to endothelial cells was
evaluated in the presence versus absence of DOCK4 in cells expressing versus deficient in
SR-B1 (c, n=6) or LDLR and CD36 (d, n=4). In c-d, P values by ANOVA with Dunnett’s
post-hoc testing are shown. e,f, nLDL and oxLDL uptake (e, n=3 for nLDL and n=8 for
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oxLDL) and transcytosis (f, n=3) in cells with normal versus decreased DOCK4 expression.
g, HDL transcytosis in cells with normal versus decreased expression of SR-B1 or DOCK4,
n=3. h,i, Rac1 is activated by nLDL (h) or oxLDL (i) via SR-B1 and DOCK4 in endothelial
cells. Left panel: Cells were treated with LDL for 0–60 min and Rac1 activity was
determined. Right panel: Rac1 activation in response to LDL was evaluated in cells
expressing or lacking SR-B1 or DOCK4. j, Rac1 activation is required for SR-B1-mediated
nLDL or oxLDL uptake in endothelial cells. Cells were transfected with GFP control versus
dominant-negative Rac1, or treated with vehicle versus the Rac1 inhibitor NSC23766; n=8.
Data are mean±SEM, in e-g and j, P values by two-sided Student’s t test are shown. See also
Extended Data Fig. 9g–m. k, Summary scheme: SR-B1 transports LDL across the
endothelial cell monolayer and thereby governs the accumulation of LDL by arterial wall
macrophages, which become foam cells and atherosclerotic lesion development ensues. The
transcytosis of LDL across the endothelial cell monolayer requires an 8 amino acid
cytoplasmic domain of SR-B1, which recruits DOCK4, and DOCK4 promotes SR-B1
internalization and LDL transport by coupling LDL binding to SR-B1 with Rac1 activation.
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